Global Cat Allergy in Humans Market Size, Status and Forecast 2022

Cat allergy in humans is an allergic reaction to one or more allergens produced by cats. The most common of these allergens are the glycoprotein Fel d 1, secreted by the cat's sebaceous glands and Fel d 4, which is expressed in saliva. An allergic reaction is a histamine reaction that is usually characterized by coughing, wheezing, chest tightening, itching, nasal congestion, rash, watering eyes, sneezing, chapped lips, and similar symptoms. In some severe cases, reactions may progress rapidly to cause the victim's airway to become inflamed and close up, requiring emergency medical attention. Those with severe, life-threatening cat allergies face tremendous challenges due to lack of public awareness about anaphylactic cat allergies.

Market Analysis and Insights: Global Cat Allergy in Humans Market
In 2021, the global Cat Allergy in Humans market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cat Allergy in Humans market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cat Allergy in Humans market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cat Allergy in Humans market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cat Allergy in Humans market.

Global Cat Allergy in Humans Scope and Market Size
Cat Allergy in Humans market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cat Allergy in Humans market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Symptom Relief Drug
Air Purifier
Allergen Blocker
Allergy Immunotherapy
Other

Segment by Application
Allergy Treatment
Allergy Prevention

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
SANOFI
Bayer
Glaxo SmithKline
Johnson & Johnson Consumer Inc
Pfizer
Alen
Rabbit Air
Blueair Classic
WINIX
Honeywell
Nature's Miracle
Pledge
Ecology Works
MESSY PET CAT
Stallergenes Greer
HAL
HollisterStier Allergy
Allergy Therapeutics